Aurobindo Pharma Buyback 2026 vs Wipro Buyback 2026

Comparison between Aurobindo Pharma Buyback 2026 and Wipro Buyback 2026.

Buyback Details

Aurobindo Pharma Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while Wipro Buyback 2026 is a Tender Offer proposed to list at BSE, NSE.

 Aurobindo Pharma LtdWipro Ltd.
LogoAurobindo Pharma Buyback 2026 LogoWipro Buyback 2026 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE, NSE
Face Value₹10 per share₹2 per share
Buyback Price₹1475 per share₹250 per share
Issue Size54,23,728 shares60,00,00,000 shares
Issue Size (Amount)₹800.00 Crores₹15,000.00 Crores
Buyback Ratio
CategoryEntitlement RatioShares Offered
Small Shareholders7 : 618,13,560
General Category2 : 24946,10,168

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

RegistrarKfin Technologies Ltd.Kfin Technologies Ltd.
Lead ManagersAxis Capital Ltd.JM Financial Ltd.
Necessity of the buyback

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.
  • Enhance long-term shareholder value.
  • Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.
  • Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

Buyback Timetable

Aurobindo Pharma Buyback 2026 and Wipro Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2026 Buyback record date is Apr 17, 2026. Wipro Buyback 2026 Buyback record date is Jun 05, 2026.

 Aurobindo Pharma LtdWipro Ltd.
Record DateApr 17, 2026Jun 05, 2026
Offer Open DateApr 23, 2026
Offer Closure DateApr 29, 2026
Last date for receipt of tender formsApr 29, 2026
Finalisation of buybackMay 07, 2026
Last Date for settlment of bidsMay 07, 2026
Last Date for extinguishment of sharesMay 18, 2026

Financial Details and Other Relevent Information

Comparison of Aurobindo Pharma Buyback 2026 and Wipro Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Aurobindo Pharma LtdWipro Ltd.
Financial

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets49,784.9745,071.5139,889.99
Total Income32,345.5829,559.2525,145.97
Profit After Tax1,582.721,211.02684.85
EBITDA6,605.005,843.003,758.00
NET Worth32,647.0029,851.00
Reserves and Surplus20,476.0319,664.2317,975.44
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2026 1330.90 1180.00 1272.16
Feb-2026 1250.85 1106.25 1179.45
Jan-2026 1270.40 1115.80 1176.03
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2026 1330.00 1179.80 1272.09
Feb-2026 1250.90 1106.00 1179.10
Jan-2026 1270.80 1116.20 1175.87

Compare with others

Compare: